Park, S., Park, J. M., Park, M., Ko, D., Kim, S., Seo, J., . . . Seo, J. H. (2022). β-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features. BMC.
Chicago Style (17th ed.) CitationPark, Soeun, et al. β-Escin Overcomes Trastuzumab Resistance in HER2-positive Breast Cancer by Targeting Cancer Stem-like Features. BMC, 2022.
MLA (9th ed.) CitationPark, Soeun, et al. β-Escin Overcomes Trastuzumab Resistance in HER2-positive Breast Cancer by Targeting Cancer Stem-like Features. BMC, 2022.
Warning: These citations may not always be 100% accurate.